Affordable Access

Clinical and cost effectiveness of a new hepatocellular MRI contrast agent, mangafodipir trisodium, in the preoperative assessment of liver resectability.

Authors
Type
Published Article
Journal
Annals of Surgical Oncology
1068-9265
Publisher
Springer - Society of Surgical Oncology
Publication Date
Volume
8
Issue
7
Pages
573–579
Identifiers
PMID: 11508618
Source
Medline

Abstract

These findings suggest that T-MRI is more sensitive than CECT in the preoperative predicting of the resectability of hepatic lesions. Despite T-MRI accurately correlating with intraoperative surgical findings, IOUS should be performed on all patients prior to a final decision to resect or ablate a focal liver lesion.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F